Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cognitive impairment and MS: searching for effective therapies.

Literature DB >> 21805080

Cognitive impairment and MS: searching for effective therapies.

Vijayshree Yadav¹, Dennis N Bourdette.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2011 PMID： 21805080 DOI： 10.1007/s11910-011-0217-8

Source DB: PubMed Journal: Curr Neurol Neurosci Rep ISSN： 1528-4042 Impact factor: 5.081

Keyword Cloud
References

× No keyword cloud information.

17 in total

1. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study.

Authors: Maria P Amato; Emilio Portaccio; Benedetta Goretti; Valentina Zipoli; Alfonso Iudice; Dario Della Pina; Gianmichele Malentacchi; Simonetta Sabatini; Pasquale Annunziata; Mario Falcini; Monica Mazzoni; Marzia Mortilla; Claudio Fonda; Nicola De Stefano
Journal: Mult Scler Date: 2010-08-20 Impact factor: 6.312

2. Effects of donepezil on memory and cognition in multiple sclerosis.

Authors: Christopher Christodoulou; Patricia Melville; William F Scherl; William S Macallister; Leigh E Elkins; Lauren B Krupp
Journal: J Neurol Sci Date: 2006-04-19 Impact factor: 3.181

3. Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis.

Authors: S Cader; J Palace; P M Matthews
Journal: J Psychopharmacol Date: 2008-07-17 Impact factor: 4.153

4. Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial.

Authors: J F Lovera; E Frohman; T R Brown; D Bandari; L Nguyen; V Yadav; O Stuve; J Karman; K Bogardus; G Heimburger; L Cua; G Remingon; J Fowler; T Monahan; S Kilcup; Y Courtney; J McAleenan; K Butler; K Wild; R Whitham; D Bourdette
Journal: Mult Scler Date: 2010-05-18 Impact factor: 6.312

5. Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial.

Authors: J Lovera; B Bagert; K Smoot; C D Morris; R Frank; K Bogardus; K Wild; B Oken; R Whitham; D Bourdette
Journal: Mult Scler Date: 2007-01-29 Impact factor: 6.312

Cognitive impairment and MS: searching for effective therapies.

1. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study.

2. Effects of donepezil on memory and cognition in multiple sclerosis.

3. Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis.

4. Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial.

5. Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial.

6. Cognition in the early stage of multiple sclerosis.

Review 7. Treatment options of cognitive impairment in multiple sclerosis.

8. Employment in multiple sclerosis. Exiting and re-entering the work force.

9. Memantine induces reversible neurologic impairment in patients with MS.

10. Effects of rivastigmine on memory and cognition in multiple sclerosis.